Orally Administered Vaccine Market, Global Outlook and Forecast 2025-2030

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Orally Administered Vaccine
1.2 Key Market Segments
1.2.1 Orally Administered Vaccine Segment by Type
1.2.2 Orally Administered Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Orally Administered Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Orally Administered Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Orally Administered Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Orally Administered Vaccine Market Competitive Landscape
3.1 Global Orally Administered Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Orally Administered Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Orally Administered Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Orally Administered Vaccine Sales Sites, Area Served, Product Type
3.6 Orally Administered Vaccine Market Competitive Situation and Trends
3.6.1 Orally Administered Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Orally Administered Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Orally Administered Vaccine Industry Chain Analysis
4.1 Orally Administered Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Orally Administered Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Orally Administered Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Orally Administered Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Orally Administered Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Orally Administered Vaccine Price by Type (2019-2024)
7 Orally Administered Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Orally Administered Vaccine Market Sales by Application (2019-2024)
7.3 Global Orally Administered Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
8 Orally Administered Vaccine Market Consumption by Region
8.1 Global Orally Administered Vaccine Sales by Region
8.1.1 Global Orally Administered Vaccine Sales by Region
8.1.2 Global Orally Administered Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Orally Administered Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Orally Administered Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Orally Administered Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Orally Administered Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Orally Administered Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Orally Administered Vaccine Market Production by Region
9.1 Global Production of Orally Administered Vaccine by Region (2019-2024)
9.2 Global Orally Administered Vaccine Revenue Market Share by Region (2019-2024)
9.3 Global Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Orally Administered Vaccine Production
9.4.1 North America Orally Administered Vaccine Production Growth Rate (2019-2024)
9.4.2 North America Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Orally Administered Vaccine Production
9.5.1 Europe Orally Administered Vaccine Production Growth Rate (2019-2024)
9.5.2 Europe Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Orally Administered Vaccine Production (2019-2024)
9.6.1 Japan Orally Administered Vaccine Production Growth Rate (2019-2024)
9.6.2 Japan Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Orally Administered Vaccine Production (2019-2024)
9.7.1 China Orally Administered Vaccine Production Growth Rate (2019-2024)
9.7.2 China Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Merck
10.1.1 Merck Orally Administered Vaccine Basic Information
10.1.2 Merck Orally Administered Vaccine Product Overview
10.1.3 Merck Orally Administered Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck Orally Administered Vaccine SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Orally Administered Vaccine Basic Information
10.2.2 GSK Orally Administered Vaccine Product Overview
10.2.3 GSK Orally Administered Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK Orally Administered Vaccine SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi
10.3.1 Sanofi Orally Administered Vaccine Basic Information
10.3.2 Sanofi Orally Administered Vaccine Product Overview
10.3.3 Sanofi Orally Administered Vaccine Product Market Performance
10.3.4 Sanofi Orally Administered Vaccine SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Orally Administered Vaccine Basic Information
10.4.2 Lanzhou Institute Orally Administered Vaccine Product Overview
10.4.3 Lanzhou Institute Orally Administered Vaccine Product Market Performance
10.4.4 Lanzhou Institute Business Overview
10.4.5 Lanzhou Institute Recent Developments
10.5 Serum Institute
10.5.1 Serum Institute Orally Administered Vaccine Basic Information
10.5.2 Serum Institute Orally Administered Vaccine Product Overview
10.5.3 Serum Institute Orally Administered Vaccine Product Market Performance
10.5.4 Serum Institute Business Overview
10.5.5 Serum Institute Recent Developments
10.6 Valneva
10.6.1 Valneva Orally Administered Vaccine Basic Information
10.6.2 Valneva Orally Administered Vaccine Product Overview
10.6.3 Valneva Orally Administered Vaccine Product Market Performance
10.6.4 Valneva Business Overview
10.6.5 Valneva Recent Developments
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Orally Administered Vaccine Basic Information
10.7.2 Shanghai United Cell Orally Administered Vaccine Product Overview
10.7.3 Shanghai United Cell Orally Administered Vaccine Product Market Performance
10.7.4 Shanghai United Cell Business Overview
10.7.5 Shanghai United Cell Recent Developments
10.8 Bibcol
10.8.1 Bibcol Orally Administered Vaccine Basic Information
10.8.2 Bibcol Orally Administered Vaccine Product Overview
10.8.3 Bibcol Orally Administered Vaccine Product Market Performance
10.8.4 Bibcol Business Overview
10.8.5 Bibcol Recent Developments
10.9 PaxVax
10.9.1 PaxVax Orally Administered Vaccine Basic Information
10.9.2 PaxVax Orally Administered Vaccine Product Overview
10.9.3 PaxVax Orally Administered Vaccine Product Market Performance
10.9.4 PaxVax Business Overview
10.9.5 PaxVax Recent Developments
10.10 Vabiotech
10.10.1 Vabiotech Orally Administered Vaccine Basic Information
10.10.2 Vabiotech Orally Administered Vaccine Product Overview
10.10.3 Vabiotech Orally Administered Vaccine Product Market Performance
10.10.4 Vabiotech Business Overview
10.10.5 Vabiotech Recent Developments
10.11 Tiantan Biological
10.11.1 Tiantan Biological Orally Administered Vaccine Basic Information
10.11.2 Tiantan Biological Orally Administered Vaccine Product Overview
10.11.3 Tiantan Biological Orally Administered Vaccine Product Market Performance
10.11.4 Tiantan Biological Business Overview
10.11.5 Tiantan Biological Recent Developments
10.12 EuBiologics
10.12.1 EuBiologics Orally Administered Vaccine Basic Information
10.12.2 EuBiologics Orally Administered Vaccine Product Overview
10.12.3 EuBiologics Orally Administered Vaccine Product Market Performance
10.12.4 EuBiologics Business Overview
10.12.5 EuBiologics Recent Developments
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Orally Administered Vaccine Basic Information
10.13.2 Panacea Biotec Ltd Orally Administered Vaccine Product Overview
10.13.3 Panacea Biotec Ltd Orally Administered Vaccine Product Market Performance
10.13.4 Panacea Biotec Ltd Business Overview
10.13.5 Panacea Biotec Ltd Recent Developments
10.14 Bio-Med
10.14.1 Bio-Med Orally Administered Vaccine Basic Information
10.14.2 Bio-Med Orally Administered Vaccine Product Overview
10.14.3 Bio-Med Orally Administered Vaccine Product Market Performance
10.14.4 Bio-Med Business Overview
10.14.5 Bio-Med Recent Developments
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Basic Information
10.15.2 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
10.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Market Performance
10.15.4 Halfkin Bio-Pharmaceuticals Business Overview
10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 Orally Administered Vaccine Market Forecast by Region
11.1 Global Orally Administered Vaccine Market Size Forecast
11.2 Global Orally Administered Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Orally Administered Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Orally Administered Vaccine Market Size Forecast by Region
11.2.4 South America Orally Administered Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Orally Administered Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Orally Administered Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Orally Administered Vaccine by Type (2025-2032)
12.1.2 Global Orally Administered Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Orally Administered Vaccine by Type (2025-2032)
12.2 Global Orally Administered Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Orally Administered Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Orally Administered Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings